Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The 2022 OncoAlert Colloquium Day 6: EONS Sessions

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 6: EONS Sessions ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 5: GI Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 4: ESGO Sessions and Gynaecological Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 3: Lung Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 3: Lung Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 2: GU Oncology

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 2: GU Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023

The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 1: Breast Cancer ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
30 Jan 2023

Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer

Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer ( Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA )
25 Jan 2023

Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients

Dr Fred Locke - Moffitt Cancer Center, Tampa, USA
Shorter time from leukapheresis to infusion of axi-cel corresponds to better CR and OS in r/r LBCL patients ( Dr Fred Locke - Moffitt Cancer Center, Tampa, USA )
23 Dec 2022

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA
Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )
22 Dec 2022

Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery

Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athens, Greece
Comment: POLAR gene profile can identify which patients can safely avoid radiation therapy after breast-conserving surgery ( Prof Christos Markopoulos- National and Kapodistrian University of Athens, Athens, Greece )
22 Dec 2022

Updates from TAILORx and RxPONDER: Implications for practice

Prof Christos Markopoulos and Dr Kevin Kalinsky
Updates from TAILORx and RxPONDER: Implications for practice ( Prof Christos Markopoulos and Dr Kevin Kalinsky )
21 Dec 2022

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery ( Prof Per Karlsson - Sahlgrenska Comprehensive Cancer Centre, Gothenburg, Sweden )
21 Dec 2022